Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0013421 (
dystonia
)
8,418
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Mohr-Tranebjaerg-Jensen deafness-
dystonia
-optic atrophy protein DDP/TIMM8a is translated on cytoplasmic ribosomes but targeted ultimately to the mitochondrial intermembrane space, where it is involved in mitochondrial protein import.
STAM1
is a cytoplasmic signal-transducing adaptor molecule implicated in cytokine signaling. We report here a direct interaction between DDP and
STAM1
, identified by yeast two-hybrid screening and confirmed by co-immunoprecipitation, fusion protein "pull downs," and nuclear redistribution assays. DDP coordinates Zn(2+), and Zn(2+) was found to stimulate the DDP-
STAM1
interaction in vitro. Endogenous
STAM1
localizes predominantly to early endosomes, and we found no evidence that
STAM1
is imported into mitochondria in vitro. Thus, the DDP-
STAM1
interaction likely occurs in the cytoplasm or at the mitochondrial outer membrane. The DDP-
STAM1
interaction requires a coiled-coil region in
STAM1
that overlaps with the immunoreceptor tyrosine-based activation motif (ITAM), a region previously shown to be important for interaction with Jak2/3 and hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs). Thus, DDP binding may alter the interactions of
STAM1
with several cytoplasmic proteins involved in cell signaling and endosomal trafficking.
...
PMID:Interaction of the deafness-dystonia protein DDP/TIMM8a with the signal transduction adaptor molecule STAM1. 1274 81